{"slideshow_credits": null, "snippet": "The Swiss pharmaceutical giant Roche will pay more than $1 billion in a deal aimed at improving both cancer treatment and drug development.", "abstract": "The Swiss pharmaceutical giant Roche will pay more than $1 billion in a deal aimed at improving both cancer treatment and drug development.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://dealbook.nytimes.com/2015/01/12/roche-to-buy-majority-stake-in-foundation-medicine-leader-in-tumor-testing/", "lead_paragraph": null, "headline": {"main": "Roche to Buy Majority Stake in Foundation Medicine, Leader in Tumor Testing", "kicker": "DealBook"}, "_id": "54b3638738f0d82eb90f0fff", "word_count": "810", "multimedia": [], "pub_date": "2015-01-12T01:01:21Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Foundation Medicine Inc", "rank": "1"}, {"name": "organizations", "value": "Roche Holding AG", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}